Trust Co. of Toledo Trims Bristol Myers Squibb Stake

Institutional investor reduces position in pharmaceutical giant by 35%

Apr. 4, 2026 at 12:12pm

Got story updates? Submit your updates here. ›

Trust Co. of Toledo NA OH, an institutional investor based in Ohio, has reduced its position in Bristol Myers Squibb Company (NYSE: BMY) by 35% in the fourth quarter, according to a recent SEC filing. The fund now owns 103,227 shares of the biopharmaceutical company's stock, down from 158,750 shares previously.

Why it matters

This move by a major institutional investor highlights the ongoing shifts in sentiment and positioning around Bristol Myers Squibb, a leading pharmaceutical firm with a diverse portfolio of drugs. Insider transactions and changes in institutional holdings can provide valuable signals about a company's near-term prospects.

The details

According to the filing, Trust Co. of Toledo sold 55,523 shares of Bristol Myers Squibb during the fourth quarter, reducing its overall stake by 35%. The fund now holds 103,227 shares of the company, valued at approximately $5.57 million based on the stock's closing price on the last trading day of the reporting period.

  • The transactions occurred in the fourth quarter of 2025.

The players

Trust Co. of Toledo NA OH

An institutional investor and fund manager based in Toledo, Ohio.

Bristol Myers Squibb Company

A global biopharmaceutical company focused on developing and delivering innovative medicines for serious diseases.

Got photos? Submit your photos here. ›

The takeaway

This transaction by Trust Co. of Toledo reflects the ongoing volatility and uncertainty surrounding the pharmaceutical industry, as investors carefully monitor factors like drug pipelines, regulatory changes, and market competition. The reduction in the fund's Bristol Myers Squibb position may signal broader concerns or a shift in investment strategy, though the reasons behind the move are not explicitly stated.